InsidersTradesSigma
Browse the full record of transactions filed by AHMED NADIM, Chairman & CEO. Insider active across 1 company, notably Cullinan Oncology, Inc.. Aggregated, 1 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €94k. History available since 6 June 2022. The latest transaction was filed on 6 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Nadim Ahmed is the Chairman & CEO of Cullinan Oncology, Inc. He is responsible for the strategic direction of the company and the management of its operations. Nadim brings expertise in business development and innovation to support the company's growth.